We are live on
!
Find out more
CWM
Cabot Wealth Management Portfolio holdings
AUM
$982M
1-Year Est. Return
21.85%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+21.85%
3 Year Est. Return
+69.26%
5 Year Est. Return
+82.26%
10 Year Est. Return
+369.65%
AUM
$369M
AUM Growth
-$19.5M
(-5%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-4.79%
Top 10 Holdings %
Top 10 Hldgs %
25.86%
Holding
160
New
11
Increased
46
Reduced
78
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Bank ETF
KBE
|
+$5.09M |
| 2 |
Vanguard Health Care ETF
VHT
|
+$2.96M |
| 3 |
Chemed
CHE
|
+$2.39M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$2.38M |
| 5 |
Duluth Holdings
DLTH
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$5.18M |
| 2 |
CVS Health
CVS
|
+$5.05M |
| 3 |
Illumina
ILMN
|
+$3.81M |
| 4 |
IQVIA
IQV
|
+$3.77M |
| 5 |
GOLD
Randgold Resources Ltd
GOLD
|
+$3.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.52% |
| 2 | Consumer Discretionary | 9.65% |
| 3 | Technology | 9.2% |
| 4 | Communication Services | 7.45% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Ligand Pharmaceuticals
LGND
$5.76B
| – | – |
-81,375
| Closed | -$5.18M |
|
152
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
| – | – |
-11,837
| Closed | -$188K |
|
153
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-8,112
| Closed | -$3.26M |
|
154
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| – | – |
-5,429
| Closed | -$204K |
|
155
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| – | – |
-48,937
| Closed | -$2.6M |
|
156
State Street SPDR S&P Retail ETF
XRT
$449M
| – | – |
-8,590
| Closed | -$374K |
|
|
SPLK
157
DELISTED
Splunk Inc
SPLK
| – | – |
-30,718
| Closed | -$1.8M |
|
|
PCI
158
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
| – | – |
-17,492
| Closed | -$357K |
|
|
ALXN
159
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-17,459
| Closed | -$2.14M |
|
|
GOLD
160
DELISTED
Randgold Resources Ltd
GOLD
| – | – |
-33,444
| Closed | -$3.35M |
|
Similar funds
MVM
BIP
SCM
PCM
FFS
MFWP
FCM
PCM
Cabot Wealth Management's Q4 2016 Portfolio in Review
As of Q4 2016, Cabot Wealth Management held 160 positions worth $369M, down 5% from $389M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cabot Wealth Management withdrew a net $17.7M in Q4 2016, closing 15 positions and reducing 78 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $5.18M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Cabot Wealth Management opened a new position in State Street SPDR S&P Bank ETF worth $5.73M.
- Cabot Wealth Management's largest Q4 2016 buy was State Street SPDR S&P Bank ETF: 131,882 shares worth $5.73M.
- Cabot Wealth Management added most to Vanguard Extended Market ETF in Q4 2016, an estimated $2.38M increase.
- Cabot Wealth Management's biggest Q4 2016 reduction was IQVIA, cutting an estimated $3.77M.
- Cabot Wealth Management fully exited Ligand Pharmaceuticals in Q4 2016, selling an estimated $5.18M.
- Cabot Wealth Management's ten largest holdings make up 26% of its $369M portfolio in Q4 2016.
- Cabot Wealth Management opened 11 new positions and closed 15 in Q4 2016.
- Cabot Wealth Management's portfolio value fell 5% quarter-over-quarter to $369M.
Based on Cabot Wealth Management's 13F filing for Q4 2016, filed 7 Feb 2017.